| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PLX4720 | CCLE | pan-cancer | AAC | 0.47 | 2e-14 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | 0.31 | 4e-07 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | 0.28 | 6e-06 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | -0.17 | 0.006 |
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | -0.16 | 0.007 |
| mRNA | TAE684 | CCLE | pan-cancer | AAC | -0.14 | 0.03 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | -0.14 | 0.04 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | -0.13 | 0.05 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | -0.17 | 0.06 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | -0.12 | 0.07 |